23 results
424B3
PROK
ProKidney Corp - Ordinary Shares
21 Apr 23
Prospectus supplement
4:18pm
regarding the potential side-effect profile of REACT and, as the clinical development program progresses, on observed side effects with REACT;
training … ; and
the ability to provide advanced procedural training for delivery of product candidates.
Sales of cell-based products also depend on the willingness
POS AM
PROK
ProKidney Corp - Ordinary Shares
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
program progresses, on observed side effects with REACT;
training medical personnel on the proper use and delivery of REACT;
enrolling sufficient numbers … liability from procedural-related or cell based adverse events; and
the ability to provide advanced procedural training for delivery of product candidates
424B3
PROK
ProKidney Corp - Ordinary Shares
9 Sep 22
Prospectus supplement
5:05pm
side-effect profile of REACT and, as the clinical development program progresses, on observed side effects with REACT;
training medical personnel … adverse events; and
the ability to provide advanced procedural training for delivery of product candidates.
Sales of cell-based products also
DEFA14A
kowlxa7 2dzk4
23 Jun 22
Additional proxy soliciting materials
4:31pm
DEFM14A
8171y
10 Jun 22
Proxy related to merger
4:54pm
DEFA14A
ahae2i
11 May 22
Additional proxy soliciting materials
4:55pm
PRER14A
te45lek
11 Apr 22
Preliminary revised proxy
5:29pm
10-K
sydofowct47qf 1bhtw7
23 Mar 22
Annual report
5:32pm
10-K
EX-14.1
9x8o1 0syshtccpoo
23 Mar 22
Annual report
5:32pm
PREM14A
4h0o7e
14 Feb 22
Preliminary proxy related to merger
4:55pm
424B4
s22v5461
1 Jul 21
Prospectus supplement with pricing info
5:20pm